GMP Microbial Cell Banking

• 

  Maintaining Sterility in GMP Microbial Cell Banking

  Any medicine has to be approved first before it goes out and helps people. Current Good Manufacturing Practice (GMP) is a set of guidelines and process rules that must be adhered to during the production of drugs for establishing quality while ensuring that everything is safe, pure and effective. GMP guidelines are regulated through organizations such as the FDA and EMA. They verify that each involves in the medication making procedure is done properly. When you are within these constraints, it makes cell banking a traceable process. Detailing such information about the cells is crucial in a scenario where regulators come to check everything and you must be able to prove all safety measures have actually been complied with.

• 

  Meeting Regulatory Standards and Guidelines

  Initials of GMP HEV Antigen Production Process take place carefully, while Sampling and Isolating microbial cells from particular environment/ host. This is performed cautiously and without contamination. When these cells are separated, they are cultivated in unique environments that encourage their growth and division. Once researchers identify the most suitable line of cells, it is frozen using a process known as cryopreservation.

• 

  The GMP Microbial Cell Banking Process Explained

  Once these cells are frozen, the cell bank stores them at -80°C, which is far below their optimal growth temperature and makes them stable for many years. The cells are kept in special containers, such as vials or capsules, created to prevent cross-contamination. So that the cells wont intermingle with other unwanted cells. And when the facilities are complete, production teams requisition the needed number of cells from inventories kept at a cell bank so they can begin making medicines.

Why choose Yaohai GMP Microbial Cell Banking?

• Professional Expertise & Extensive Experience

  GMP Microbial Cell Banking is a leading in microbial biologics CDMO. Our focus has been on microbial-produced vaccines and therapeutics that are suited for human, veterinary, as well as pet health management. We have the most cutting-edge RD platforms and manufacturing technology which cover the entire procedure beginning with the development of microbial strains and cell banking, to process and method development, to commercial and clinical production which ensures successful delivery of innovative solutions. Over time, we have accumulated vast knowledge of microbial-based bio processing. Over 200 projects have been successfully completed, and we assist our clients to comply with regulations like those of US FDA and EU EMA. We also help them to navigate Australia TGA and China NMPA. Our professional expertise and extensive experience allows us to quickly respond to market demands and provide bespoke CDMO services.

• Quality System & Global Regulatory Compliance

  Yaohai BioPharma, a GMP Microbial Cell Banking Microbial CDMO, integrates regulatory affairs and quality management. We have a quality system that is compliant with current GMP standards, as well as regulations around the globe. Our regulatory team is knowledgeable in global regulatory frameworks to expedite biological launches. We make sure that production processes are traceable, high-quality products, and complying with the rules of the US FDA and EU EMA. Australia TGA and China NMPA is also fulfilled. Yaohai BioPharma has successfully passed the audit on site of the European Union's Qualified Person (QP) to ensure our GMP quality system and production site. We also have passed the initial certification audits of the ISO9001 Quality Management System and ISO14001 Environmental Management System.

• Robust Supply Chain & Manufacturing Capabilities

  Yaohai Bio-Pharma, a top 10 producer of GMP Microbial Cell Banking, specializes in microbial fermentation. We have set up a modern facility with advanced facilities as well as robust RD manufacturing capabilities. Five production lines for drug substances complying with GMP standards for microbial purification and ferment along with two automated fill and finish lines for vials as well as cartridges as well as pre-filled needles are readily available. The available fermentation scales range between 100L and 2000L. Vial filling specifications cover 1ml - 25ml. the pre-filled cartridge or syringe filling specifications are between 1-3ml. The production workshop is cGMP certified and offers the availability of commercial and clinical samples. Our plant produces big molecules that are exported to all over the world.

• Customization, Efficiency & Cost-Effectiveness

  Yaohai Bio-Pharma is GMP Microbial Cell Banking in microbial-derived biologics. We offer custom RD as well as manufacturing solutions, while minimising the risk. We've been involved in numerous modalities like recombinant subunit vaccines, peptides hormones, cytokines growth factors, single-domain antibodies, enzymes, plasmid DNA, the mRNA, and other. We are experts in several Microbial hosts, such as yeast extracellular and intracellular (yield up to 15 grams per liter) bacteria periplasmic secretion as well as soluble intracellular inclusion bodies (yield up to 10 grams/L). Additionally, we have developed the BSL-2 microbial fermentation platform for the development of bacterial vaccines. We have a track record of improving production processes, thereby increasing yields, and reducing costs. With a highly efficient technology team, we guarantee prompt and reliable project delivery and bring your products to market quicker.

Related product categories

• Analytical Methods for Plasmid DNA
• Bacteriophage AP205 VLP Manufacturing
• Bacteriophage Q VLP Manufacturing
• Chimeric VLP Vaccine Manufacturing
• Conjugate VLP Vaccines Manufacturing
• DNA Vaccine Manufacturing
• E. coli Fermentation for VLP Production
• GLP-1 Agonist Manufacturing
• GLP-1 Analog Manufacturing

Not finding what you're looking for?
Contact our consultants for more available products.